Last viewed: AGNPF


Prices are updated after-hours


nasdaq:AGNPF Algernon Pharmaceuticals Inc.

AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (132.6% 1m) (10681.1% 1y) (0.0% 2d) (-12.9% 3d) (14.5% 7d) (-36.58% volume)
http://www.algernonpharmaceuticals.com
Sec Filling | Patents | n/a employees

Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.

add to today's watch list email alert is off




urea   kidney diseases  

Press-releases


Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
Published: 2022-01-19 (Crawled : 12:30) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: 1.33% H: 1.73% C: -14.06%

als trial approval stroke phase 1
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study
Published: 2022-01-14 (Crawled : 15:00) - biospace.com/
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: 9.2% H: 0.0% C: -4.78%

fda phase 2 als ces phase 2b positive chronic cough
Streetwise Reports – Algernon Pharmaceuticals Looks to U.S. for Help Fighting Strokes
Published: 2022-01-05 (Crawled : 03:00) - algernonpharmaceuticals.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: -2.17% H: 9.52% C: 9.52%

als stroke
Algernon Pharmaceuticals Issues Compensation Options
Published: 2022-01-04 (Crawled : 19:00) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: -0.03%

als
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
Published: 2021-12-08 (Crawled : 12:30) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology

phase 2 drug stroke
Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial
Published: 2021-12-02 (Crawled : 16:00) - biospace.com/
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology

phase 2 trial chronic cough
Algernon Pharmaceuticals Announces New Chief Financial Officer
Published: 2021-11-30 (Crawled : 12:00) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology

MCUJF | $0.83 | twitter stocktwits trandingview |
Health Technology


Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Published: 2021-11-24 (Crawled : 12:00) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: 14515.38% H: 0.0% C: -1.95%

fda lung cancer phase 1 positive cancer
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study
Published: 2021-11-19 (Crawled : 12:00) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -2.5%

stroke phase 1 positive
Algernon Pharmaceuticals Announces Share Consolidation
Published: 2021-11-17 (Crawled : 23:00) - globenewswire.com
AGNPF | News | $7.6977 | twitter stocktwits trandingview |
Health Technology
| | O: -4.23% H: 3.41% C: -19.68%


See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying